Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cuiting Wei

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|September 8, 2022
Primary cilium in kidney development, function and diseaseYunfeng Bai, Cuiting Wei, Ping Li, et al.
Frontiers in Pharmacology|April 24, 2023
Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidneyRun Li, Chunru Shi, Cuiting Wei, et al.
Heliyon|December 7, 2023
The pharmacological mechanism of <i>Abelmoschus manihot</i> in the treatment of chronic kidney diseaseCuiting Wei, Chao Wang, Run Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 31, 2023
Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKTRun Li, Chunru Shi, Cuiting Wei, et al.
Kidney Diseases (Basel, Switzerland)|December 15, 2023
Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease AnemiaXue Wang, Cuiting Wei, Delong Zhao, et al.
Frontiers in Endocrinology|December 5, 2022
Renal primary cilia lengthen in the progression of diabetic kidney diseaseYunfeng Bai, Ping Li, Jiaona Liu, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 20, 2026
Tyrosine hydroxylase as a therapeutic target: insights from adrenergic nerve and TNBC cell interactionsYichen Luo, Yanhong Han, Huilong Nie, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|September 8, 2022
Primary cilium in kidney development, function and diseaseYunfeng Bai, Cuiting Wei, Ping Li, et al.
Frontiers in Pharmacology|April 24, 2023
Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidneyRun Li, Chunru Shi, Cuiting Wei, et al.
Heliyon|December 7, 2023
The pharmacological mechanism of <i>Abelmoschus manihot</i> in the treatment of chronic kidney diseaseCuiting Wei, Chao Wang, Run Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 31, 2023
Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKTRun Li, Chunru Shi, Cuiting Wei, et al.
Kidney Diseases (Basel, Switzerland)|December 15, 2023
Iron Supplements Concomitant within Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitors in the Treatment of Chronic Kidney Disease AnemiaXue Wang, Cuiting Wei, Delong Zhao, et al.
Frontiers in Endocrinology|December 5, 2022
Renal primary cilia lengthen in the progression of diabetic kidney diseaseYunfeng Bai, Ping Li, Jiaona Liu, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 20, 2026
Tyrosine hydroxylase as a therapeutic target: insights from adrenergic nerve and TNBC cell interactionsYichen Luo, Yanhong Han, Huilong Nie, et al.
Pageof 1